Stimcell Energetics (STME) Net Cash Flow Growth (3y) (2016 - 2026)
Stimcell Energetics (STME) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 269.22% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | -50.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -50.02% |
| Nov 30, 2025 | 65.76% |
| Aug 31, 2025 | 17.79% |
| May 31, 2025 | 47.09% |
| Feb 28, 2025 | -58.57% |
| Nov 30, 2024 | 36.04% |
| Aug 31, 2024 | -36.39% |
| May 31, 2024 | -82.01% |
| Feb 29, 2024 | 224.22% |
| Nov 30, 2023 | 28.86% |
| Aug 31, 2023 | -36.33% |
| May 31, 2023 | 49.50% |
| Feb 28, 2023 | 59.43% |
| Nov 30, 2022 | 28.32% |
| Aug 31, 2022 | -27.03% |
| May 31, 2022 | 54.49% |
| Feb 28, 2022 | -27.29% |
| Nov 30, 2021 | -91.29% |
| Aug 31, 2021 | 100.23% |
| May 31, 2021 | 26.67% |